1992
DOI: 10.1016/s0021-9258(19)49722-6
|View full text |Cite
|
Sign up to set email alerts
|

Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
30
0
1

Year Published

1993
1993
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 352 publications
(31 citation statements)
references
References 39 publications
0
30
0
1
Order By: Relevance
“…A MAPKK (mekl) has been purified and cloned in several laboratories Ashworth et al, 1992;Seger et al, 1992;Wu et al, 1993). To determine whether the enzymic properties of this protein are consistent with the characteristics of the in vivo phosphorylation and activation of MAP kinase described above, we analysed the phosphorylation of MAP kinase mutants using purified MAPKK in vitro.…”
Section: Phosphorylation Of Map Kinase In Vitromentioning
confidence: 99%
See 1 more Smart Citation
“…A MAPKK (mekl) has been purified and cloned in several laboratories Ashworth et al, 1992;Seger et al, 1992;Wu et al, 1993). To determine whether the enzymic properties of this protein are consistent with the characteristics of the in vivo phosphorylation and activation of MAP kinase described above, we analysed the phosphorylation of MAP kinase mutants using purified MAPKK in vitro.…”
Section: Phosphorylation Of Map Kinase In Vitromentioning
confidence: 99%
“…We also utilized kinasedefective variants of MAP kinase with mutations in either the ATP-binding loop or the catalytic loop, and obtained data suggesting that the activity or structure of the catalytic loop of MAP kinase plays an important role in its own dual phosphorylation. al., 1992; Kosako et al, 1992), purification Seger et al, 1992;Matsuda et al, 1992;Wu et al, 1992) and cloning Seger et al, 1992;Ashworth et al, 1992;Wu et al, 1993) of MAP kinase kinases (MAPKKs; mekl). MAPKKs appear to be dual-specificity protein kinases, capable of phosphorylating both the regulatory threonine and tyrosine residues, and hence enzymically activating p42malk and p44mavk in vitro. Dual-specificity kinases are a recently described class ofprotein kinases.…”
Section: Introductionmentioning
confidence: 99%
“…Our current data suggest that vault complex–dependent mvtRNA transportation in neurites may serve as a downstream signaling event of Aurora-A activation and enhance the activation of ERK in the synaptic region. MEK is a regulatory component of the MAPK signaling pathway, and its target sites for phosphorylation are very limited, with most activity directed at ERK ( Ordan et al, 2018 ; Seger et al, 1992 ; Yuan et al, 2018 ). Because previous studies have reported that vtRNA directly controls protein function, we hypothesized that mvtRNA can bind to and regulate MEK1.…”
Section: Resultsmentioning
confidence: 99%
“…10 ). MEK is a dual-specificity protein kinase that can phosphorylate both the threonine and tyrosine residues of ERK ( Seger et al, 1992 ; Yuan et al, 2018 ). Much information has been accumulated about the relationship between the structure and activity of MEK.…”
Section: Discussionmentioning
confidence: 99%
“…Two MAP kinases, p42maPk and p44mapk, have been well characterized in many mammalian cell systems (33,41). Both enzymes are phosphorylated on tyrosine and threonine and are activated by a novel protein kinase termed MAP kinase kinase (MKK), also known as MAP kinase/extracellular signal-regulated kinase (MEK) kinase (9,15,29,34,37). The activity of MKK is specific for the regulatory residues, threonine 183 and tyrosine 185, in p42maPk (32), suggesting that MKK is a key regulator of MAP kinases in the cell.…”
mentioning
confidence: 99%